MedPath

Wavefront-guided vs. Topography-guided LASIK

Not Applicable
Active, not recruiting
Conditions
Myopia
Interventions
Procedure: Wavefront-guided LASIK
Procedure: Wavefront-guided
Registration Number
NCT05588882
Lead Sponsor
Stanford University
Brief Summary

The study is comparing outcomes of wavefront-guided LASIK to topography-guided LASIK in a randomized contralateral fellow eye study in myopic participants.

Detailed Description

The purpose of the study is to compare the results of wavefront-guided LASIK surgery to topography-guided LASIK surgery in participants with nearsightedness with or without astigmatism

Three FDA-approved laser devices are being used for the study.

Two excimer lasers are being used for the study. The excimer laser is used to perform the reshaping of the cornea under a LASIK flap to correct nearsightedness, farsightedness and astigmatism. The two lasers being utilized are the Johnson and Johnson Visx CustomVue excimer laser and the Alcon Allegretto laser in the study. Both have received FDA-approval via a PMA pathway.

One femtosecond laser is being used in the study. The femtosecond laser is used to create the LASIK flap during the first part of the LASIK procedure. The Intralase iFS150 femtosecond laser is being used in the study. The femtosecond laser received FDA- approval via a 510k pathway.

All three lasers are being used according to their approved indications.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Wavefront-guided LASIKWavefront-guided LASIKWavefront-guided LASIK for myopia and myopic astigmatism
Topography-guided LASIKWavefront-guidedTopography-guided LASIK for myopia and myopic astigmatism
Primary Outcome Measures
NameTimeMethod
Percentage of eyes achieving uncorrected visual acuityOne year

Percentage of eyes achieving an uncorrected visual acuity of 20/40, 20/25 ,20/20, 20/16, 20/12.5 and 20/10 at post-operative month twelve

Secondary Outcome Measures
NameTimeMethod
Percentage of eyes with a change in two or more lines of corrected visual acuityOne year

Percentage of eyes gaining or losing two or more lines of corrected visual acuity Percentage of eyes gaining or losing 2 or more lines of corrected distance visual acuity

Patient Quality of VisionOne year

Percentage of patients preferring the eye that underwent either Wavefront-guided or Topography-guided LASIK

PredictabilityOne year

Percentage of eyes within +/- 0.50 and +/- 1.00 diopters of the intended corrected

Change in corneal epithelial thicknessOne year

We will be measuring the average change in central corneal epithelial thickness from preoperative to post-operative month12 in eyes undergoing Wavefront-guided LASIK and Topography-guided LASIK

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath